17 , 18 , 82 Pemmaraju et al reported a nonsignificant trend toward improved survival among patients treated for frontline occult CNS disease, supporting the potential benefit of upfront intrathecal therapies. 81 In our practice, we perform a diagnostic LP at the time of BPDCN diagnosis, relapse, or any signs of neurologic symptoms.
← all excerpts
Clinical Insights into the Management of Blastic Plasmacytoid Dendritic Cell Neoplasm.
1
—
—